Lyn inhibits osteoclast differentiation by interfering with PLCgamma1-mediated Ca2+ signaling

Soo-Hyun Yoon1, Youngkyun Lee, Hyung-Joon Kim

  • 1Department of Cell and Developmental Biology, Seoul National University, Seoul, Republic of Korea.

FEBS Letters
|March 17, 2009
PubMed

Insights

Lyn negatively regulates osteoclastogenesis, the process of bone resorption. Reducing Lyn enhances signaling pathways crucial for osteoclast differentiation, leading to increased bone loss.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Osteoclasts are specialized cells derived from macrophages responsible for bone resorption.
  • Osteoclast differentiation is tightly regulated by signaling pathways, including those initiated by the receptor activator of NF-kappaB ligand (RANKL).

Purpose of the Study:

  • To investigate the role of Lyn, a protein tyrosine kinase, in osteoclast differentiation.
  • To elucidate the molecular mechanisms by which Lyn influences RANKL-mediated signaling.

Main Methods:

  • Proteomics analysis to identify proteins affected by osteoclast differentiation factor RANKL.
  • Experimental manipulation of Lyn expression (forced reduction) in osteoclast precursors.
  • Assessment of downstream signaling molecules, including PLCgamma1, intracellular calcium (Ca2+), and NFATc1 activation.
  • In vivo studies using siRNA to inhibit Lyn in mouse calvariae models.

Main Results:

  • Lyn protein levels were found to be down-regulated by RANKL during osteoclast differentiation.
  • Forced reduction of Lyn significantly amplified RANKL-induced signaling, including PLCgamma1 activation, Ca2+ influx, and NFATc1 nuclear translocation.
  • Inhibition of Lyn in vivo resulted in pronounced bone resorption in mouse calvariae.

Conclusions:

  • Lyn acts as a negative regulator of osteoclastogenesis.
  • Lyn interferes with RANKL-induced PLCgamma1-mediated Ca2+ signaling, thereby inhibiting NFATc1 activation and osteoclast differentiation.
  • These findings reveal a novel mechanism for the control of bone resorption by Lyn.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...